AbbVie Inc. (ABBV)
205.15
2.43 (1.20%)
At close: Mar 28, 2025, 3:59 PM
204.77
-0.19%
After-hours: Mar 28, 2025, 06:52 PM EDT
AbbVie Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 |
| Revenue | 56.33B | 54.32B | 58.05B | 56.2B | 45.8B | 33.27B | 32.75B | 28.22B | 25.64B | 22.86B | 19.96B | 18.79B | 18.38B | 17.44B | 15.64B | 14.21B |
| Cost of Revenue | 16.9B | 20.41B | 17.41B | 17.45B | 15.39B | 7.44B | 7.72B | 7.04B | 5.83B | 4.5B | 4.43B | 4.58B | 4.51B | 4.64B | 4.29B | 4.06B |
| Gross Profit | 39.43B | 33.9B | 40.64B | 38.75B | 30.42B | 25.83B | 25.04B | 21.18B | 19.8B | 18.36B | 15.53B | 14.21B | 13.87B | 12.8B | 11.35B | 10.16B |
| Operating Income | 9.14B | 12.76B | 18.12B | 17.92B | 11.36B | 12.98B | 6.38B | 9.54B | 9.34B | 7.54B | 3.41B | 5.66B | 6.62B | 3.62B | 4.72B | 4.93B |
| Interest Income | 648M | 540M | 186M | 39M | 174M | 275M | 204M | 146M | 82M | 33M | 38M | 21M | 20M | 20M | 28M | n/a |
| Pretax Income | 3.72B | 6.25B | 13.48B | 12.99B | 3.4B | 8.43B | 5.2B | 7.73B | 7.88B | 6.64B | 2.37B | 5.33B | 5.72B | 3.67B | 4.84B | 5.95B |
| Net Income | 4.28B | 4.86B | 11.84B | 11.54B | 4.62B | 7.88B | 5.69B | 5.31B | 5.95B | 5.14B | 1.77B | 4.13B | 5.28B | 3.43B | 4.18B | 4.64B |
| Selling & General & Admin | 14.75B | 12.87B | 15.26B | 12.35B | 11.3B | 6.94B | 7.4B | 6.28B | 5.86B | 6.39B | 7.72B | 5.35B | 4.99B | 5.89B | 3.82B | 3.35B |
| Research & Development | 12.79B | 8.45B | 6.51B | 7.08B | 6.56B | 6.41B | 10.33B | 4.98B | 4.37B | 4.29B | 3.3B | 2.85B | 2.78B | 2.62B | 2.5B | 1.71B |
| Other Expenses | 2.75B | n/a | 56M | 432M | -5.61B | -890M | -18M | -513M | -232M | -13M | 27M | 1M | 9M | n/a | 61M | n/a |
| Operating Expenses | 30.29B | 21.15B | 21.83B | 19.86B | 17.86B | 12.46B | 18.23B | 11.26B | 10.22B | 10.67B | 11.77B | 8.21B | 7.77B | 8.51B | 6.32B | 5.06B |
| Interest Expense | 2.81B | 2.22B | 2.23B | 2.42B | 2.45B | 1.78B | 1.35B | 1.15B | 1.05B | 719M | 429M | 299M | 104M | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | 2.2B | 2B | 2.1B | 1.8B | 1.1B | 1.1B | 846M | 764M | 704M | 665M | 626M | 506M | n/a | n/a | n/a |
| Cost & Expenses | 47.2B | 41.56B | 39.94B | 38.27B | 34.44B | 20.28B | 26.37B | 18.67B | 16.3B | 15.32B | 16.55B | 13.13B | 12.57B | 13.15B | 10.61B | 9.11B |
| Income Tax | -570M | 1.38B | 1.63B | 1.44B | 1.22B | 544M | 490M | 2.42B | 1.93B | 1.5B | 595M | 1.2B | 450M | 235.4M | 658M | 1.31B |
| Shares Outstanding (Basic) | 1.77B | 1.77B | 1.77B | 1.77B | 1.67B | 1.48B | 1.54B | 1.6B | 1.62B | 1.63B | 1.59B | 1.59B | 1.58B | 1.62B | 1.62B | 1.62B |
| Shares Outstanding (Diluted) | 1.77B | 1.77B | 1.78B | 1.78B | 1.67B | 1.48B | 1.55B | 1.6B | 1.63B | 1.64B | 1.61B | 1.6B | 1.58B | 1.63B | 1.63B | 1.63B |
| EPS (Basic) | 2.42 | 2.73 | 6.65 | 6.48 | 2.73 | 5.30 | 3.69 | 3.31 | 3.65 | 3.15 | 1.11 | 2.58 | 3.35 | 2.12 | 2.59 | 2.87 |
| EPS (Diluted) | 2.41 | 2.72 | 6.63 | 6.45 | 2.72 | 5.28 | 3.68 | 3.30 | 3.63 | 3.13 | 1.10 | 2.56 | 3.35 | 2.11 | 2.57 | 2.85 |
| EBITDA | 14.91B | 17.31B | 31.42B | 28.28B | 21.15B | 16.26B | 13.69B | 11.77B | 10.81B | 9.69B | 6.29B | 6.91B | 6.98B | 4.94B | 6.02B | 6.65B |
| Depreciation & Amortization | 8.39B | 8.7B | 8.47B | 8.52B | 6.47B | 2.02B | 1.76B | 1.5B | 1.19B | 836M | 786M | 897M | 1.15B | 1.27B | 1.18B | 697.49M |